Assay Detail

CHEMBL5037019

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding

Potentiation of wild type CFTR (unknown origin) expressed in HBE cells assessed as change in short circuit current in presence of forskolin and amiloride

ChEMBL ↗

Free Research Context This assay will appear in recent viewed items on this browser. Open the demo workspace to preview project-only review queues.

Research home Demo workspace

Target

Cystic fibrosis transmembrane conductance regulator (CHEMBL4051) ↗

Open DB target context

Use one target anchor to keep assay intent, target linkage, and tested compound review aligned.

Loading context

Cystic fibrosis transmembrane conductance regulator (CHEMBL4051) is the working anchor for this assay review. Loading the live Open DB target snapshot…

Primary target Cystic fibrosis transmembrane conductance regulator

CHEMBL4051

Anchored from Assay target.

Protein identity Cystic fibrosis transmembrane conductance regulator

Disease frame Disease evidence pending

Open the live target snapshot or evidence card before reviewing assay metadata so target fit and disease framing stay reusable.

Review focus Open DB context pending

Open the live target snapshot before relying on this target frame across surface handoff.

Open target snapshot Open evidence card Search with this context

Total Activities

Compounds Tested

Activity Types

Assay Parameters

Assay Information

Assay Type	Binding
Organism	Homo sapiens
Cell Type	HBE
Confidence	9 — Direct single protein target
Curated By	Autocuration

Target

Cystic fibrosis transmembrane conductance regulator (CHEMBL4051) ↗

Type	SINGLE PROTEIN
Organism	Homo sapiens

Publication

Discovery of Icenticaftor (QBW251), a Cystic Fibrosis Transmembrane Conductance Regulator Potentiator with Clinical Efficacy in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Grand DL, Gosling M, Baettig U, Bahra P, Bala K, Brocklehurst C, Budd E, Butler R, Cheung AK, Choudhury H, Collingwood SP, Cox B, Danahay H, Edwards L, Everatt B, Glaenzel U, Glotin AL, Groot-Kormelink P, Hall E, Hatto J, Howsham C, Hughes G, King A, Koehler J, Kulkarni S, Lightfoot M, Nicholls I, Page C, Pergl-Wilson G, Popa MO, Robinson R, Rowlands D, Sharp T, Spendiff M, Stanley E, Steward O, Taylor RJ, Tranter P, Wagner T, Watson H, Williams G, Wright P, Young A, Sandham DA.
J Med Chem (2021) 64 : 7241 -7260
PubMed 34028270 · DOI

Activity Statistics

Type	Count	Avg pChEMBL	Best pChEMBL
EC50	2	7.31	7.47

Compounds Tested

Compound	Name	Phase	Activities	Best pChEMBL
CHEMBL2010601	IVACAFTOR	4.0	1	7.47
CHEMBL4650318	ICENTICAFTOR	2.0	1	7.14

Activity Data

Compound	Name	Type	Rel.	Value	Units	pChEMBL
CHEMBL2010601	IVACAFTOR	EC50	=	34.0	nM	7.47
CHEMBL4650318	ICENTICAFTOR	EC50	=	72.0	nM	7.14